Registry study for people with rectal cancer in Montpellier
Treatments studied
Part of Cancer, Digestive system clinical trials.
This is a hospital-based study that builds a clinical and biological database for people treated for rectal cancer at the Montpellier Cancer Institute. It helps researchers organize health information to better understand rectal cancer and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were treated at the Montpellier Cancer Institute for rectal cancer (any treatment type is okay).
- You are older than 18 years.
- You can (and agree to) sign informed consent to join the study.
- You are part of France’s Social Protection system (health coverage).
- You can understand and follow study instructions, even with support if needed.
- You are not under legal guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a clinical and biological database for people newly diagnosed with certain cancers. It may help doctors better understand cancer patterns and improve future care, and it involves agreeing to extra blood samples.
This study collects medical information and small tissue or fluid samples from people with peritoneal (abdominal lining) cancer. It aims to better understand the disease and improve future care plans.
This study builds a database of people with colorectal cancer. It may help doctors learn from real-world information to improve future care.
This study builds a large medical database of people with primary brain or spinal cord tumors treated at the Montpellier Cancer Institute. It may help researchers understand patterns of care and outcomes, which can guide future research and treatment decisions.
This study collects clinical information and planned blood samples to better understand “cachexia,” which is a serious wasting condition that can happen with advanced cancer. It may help doctors find better ways to predict and manage symptoms in people with colon cancer who can’t have surgery.
This study collects clinical and lab information from people who have surgery for colon cancer (or certain precancer growths) and related spread to organs. It may help researchers better understand colon cancer and improve future care, but it is not a new medication trial.
Hear when a new Rectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.